Drug Metabolism
Binding of drugs to hepatocytes characterized
Published in Hepatitis Weekly, April 18th, 2005
In a recent study from England, the "binding of 17 drugs to rat hepatocytes" was "determined using equilibrium dialysis in combination with metabolic inhibitors and a kinetic model for the binding and dialysis processes."
"Metabolic inhibitors were used to retard the main routes of metabolism such that the half-life for turnover of the drugs was comparable to or greater than the time scale of the equilibrium dialysis process," explained R.P. Austin and coauthors at AstraZeneca R&D Charnwood.
"Further experiments were carried out to determine the kinetics...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-04-18)
More Articles from Hepatitis Weekly
- Allergy and Immunology
Mimicry by hepatitis C virus envelope protein E2 allows immune escape - Diagnostics
Microarray differentiates wild-type and drug-resistant hepatitis B in serum - Oncology
Environmental factors modify genetic susceptibility to primary liver cancer - Transplant Medicine
Liver donor-specific IFN-gamma-producing cells denote HCV recurrence risk - Zoonosis
Gibbon hepatitis B infections hamper prevention efforts in South-East Asia - Business & Finance
Cubist issues common stock in exchange for royalty rate reduction - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
